Supplementary Figure 1: Introducing dendritic cell antibody internalization as an immunogenicity risk assessment tool
figureposted on 2022-05-20, 14:13 authored by Rachel Melendez, Benjamin Ordonia, Joyce Guerrero, Azadeh Hassanzadeh, Peter Tran, Justin Low, Manda Wong, Jochen Brumm, Shan Chung, Lynn Kamen
Supplemental Figure 1. Bioanalytical characterization of biotherapeutic panel. The test molecules were analyzed for aggregation via SEC-MALs and Uncle Thermal Stability/Tagg.